Genomic insights into Group A Streptococcus pathogenesis

Simple item page
dc.contributor.advisorEngel, Mark
dc.contributor.advisorMoodley, Clinton
dc.contributor.authorRampersadh, Kimona
dc.date.accessioned2026-01-22T07:14:31Z
dc.date.available2026-01-22T07:14:31Z
dc.date.issued2025
dc.date.updated2026-01-22T07:06:00Z
dc.description.abstractGroup A Streptococcus (GAS) is a bacterium responsible for invasive and non-invasive infections in humans. The sequela of an untreated or undertreated GAS pharyngitis include Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD). Despite evidence for the effectiveness of antibiotics such as penicillin, the burden of GAS remains high in low- and middle-income countries (LMICs) compared to high-income countries (HIC), thus necessitating the development of innovative prevention tools and improve treatment strategies tailored to LMICs. However, the pathogenetic role of GAS is poorly understood. There remains limited studies conducted across Africa, compared with HICs, documenting virulence profiles associated with GAS infection, despite the fact that an increased burden of GAS is seen in LMICs. Only a few whole genome sequencing (WGS) studies in GAS have been conducted in Africa, but none have been performed in Southern Africa. To address this knowledge gap, first, I conducted evidence-based reviews on virulence factors in invasive GAS disease (study 1) and antimicrobial resistance (AMR) of GAS in LMICs (study 2). Thereafter, on a collection of invasive and non-invasive GAS isolates from Cape Town, South Africa, performed antimicrobial susceptibility testing (study 3) and employed WGS to identify the frequency of virulence factors and AMR determinants (study 4). In brief, I provide comprehensive evidence-based data linking hasA, speA, speK, and speG to invasive GAS infections, while factors like smeZ, ssa, and sic show inverse associations; document penicillin's continued high efficacy, alongside notable resistance to macrolides and tetracycline observed in LMICs; I demonstrate low levels of antimicrobial resistance in GAS in Cape Town, with most antibiotics being effective and only minimal resistance to macrolides and tetracycline; I report that GAS isolates from Cape Town exhibit a diverse range of virulence factors and AMR genes, with notable geographic variations. My research contributes to the growing evidence base to inform future efforts at global control of GAS infections. In addition to confirming antibiotic sensitivities peculiar to our setting, suggest that GAS profile variations should be taken into account to gain a deeper understanding of GAS infection in a local context.
dc.identifier.apacitationRampersadh, K. (2025). <i>Genomic insights into Group A Streptococcus pathogenesis</i>. (). University of Cape Town ,Faculty of Health Sciences ,Department of Medicine. Retrieved from http://hdl.handle.net/11427/42645en_ZA
dc.identifier.chicagocitationRampersadh, Kimona. <i>"Genomic insights into Group A Streptococcus pathogenesis."</i> ., University of Cape Town ,Faculty of Health Sciences ,Department of Medicine, 2025. http://hdl.handle.net/11427/42645en_ZA
dc.identifier.citationRampersadh, K. 2025. Genomic insights into Group A Streptococcus pathogenesis. . University of Cape Town ,Faculty of Health Sciences ,Department of Medicine. http://hdl.handle.net/11427/42645en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - Rampersadh, Kimona AB - Group A Streptococcus (GAS) is a bacterium responsible for invasive and non-invasive infections in humans. The sequela of an untreated or undertreated GAS pharyngitis include Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD). Despite evidence for the effectiveness of antibiotics such as penicillin, the burden of GAS remains high in low- and middle-income countries (LMICs) compared to high-income countries (HIC), thus necessitating the development of innovative prevention tools and improve treatment strategies tailored to LMICs. However, the pathogenetic role of GAS is poorly understood. There remains limited studies conducted across Africa, compared with HICs, documenting virulence profiles associated with GAS infection, despite the fact that an increased burden of GAS is seen in LMICs. Only a few whole genome sequencing (WGS) studies in GAS have been conducted in Africa, but none have been performed in Southern Africa. To address this knowledge gap, first, I conducted evidence-based reviews on virulence factors in invasive GAS disease (study 1) and antimicrobial resistance (AMR) of GAS in LMICs (study 2). Thereafter, on a collection of invasive and non-invasive GAS isolates from Cape Town, South Africa, performed antimicrobial susceptibility testing (study 3) and employed WGS to identify the frequency of virulence factors and AMR determinants (study 4). In brief, I provide comprehensive evidence-based data linking hasA, speA, speK, and speG to invasive GAS infections, while factors like smeZ, ssa, and sic show inverse associations; document penicillin's continued high efficacy, alongside notable resistance to macrolides and tetracycline observed in LMICs; I demonstrate low levels of antimicrobial resistance in GAS in Cape Town, with most antibiotics being effective and only minimal resistance to macrolides and tetracycline; I report that GAS isolates from Cape Town exhibit a diverse range of virulence factors and AMR genes, with notable geographic variations. My research contributes to the growing evidence base to inform future efforts at global control of GAS infections. In addition to confirming antibiotic sensitivities peculiar to our setting, suggest that GAS profile variations should be taken into account to gain a deeper understanding of GAS infection in a local context. DA - 2025 DB - OpenUCT DP - University of Cape Town KW - Group A Streptococcus KW - Rheumatic Fever KW - Rheumatic Heart Disease LK - https://open.uct.ac.za PB - University of Cape Town PY - 2025 T1 - Genomic insights into Group A Streptococcus pathogenesis TI - Genomic insights into Group A Streptococcus pathogenesis UR - http://hdl.handle.net/11427/42645 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/42645
dc.identifier.vancouvercitationRampersadh K. Genomic insights into Group A Streptococcus pathogenesis. []. University of Cape Town ,Faculty of Health Sciences ,Department of Medicine, 2025 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/42645en_ZA
dc.language.isoen
dc.language.rfc3066eng
dc.publisher.departmentDepartment of Medicine
dc.publisher.facultyFaculty of Health Sciences
dc.publisher.institutionUniversity of Cape Town
dc.subjectGroup A Streptococcus
dc.subjectRheumatic Fever
dc.subjectRheumatic Heart Disease
dc.titleGenomic insights into Group A Streptococcus pathogenesis
dc.typeThesis / Dissertation
dc.type.qualificationlevelDoctoral
dc.type.qualificationlevelPhD
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_hsf_2025_rampersadh kimona.pdf
Size:
7.52 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
PhD / Doctoral